Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.02
+3.82 (1.69%)
At close: Jun 26, 2026, 4:00 PM EDT
228.07
-1.95 (-0.85%)
After-hours: Jun 26, 2026, 6:07 PM EDT
Jazz Pharmaceuticals Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Jazz Pharmaceuticals stock have an average target of 260.47, with a low estimate of 226 and a high estimate of 307. The average target predicts an increase of 13.24% from the current stock price of 230.02.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Jazz Pharmaceuticals stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 9 | 10 | 10 |
| Buy | 5 | 5 | 5 | 6 | 7 | 7 |
| Hold | 1 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 18, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $265 | Buy | Maintains | $265 | +15.21% | Jun 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $301 | Buy | Reiterates | $301 | +30.86% | Jun 16, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $275 | Buy | Maintains | $275 | +19.55% | Jun 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $307 | Buy | Reiterates | $307 | +33.47% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
4.51B
from 4.27B
Increased by 5.79%
Revenue Next Year
4.84B
from 4.51B
Increased by 7.18%
EPS This Year
25.39
from 8.38
Increased by 202.97%
EPS Next Year
25.61
from 25.39
Increased by 0.88%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.8B | 5.1B | |
| Avg | 4.5B | 4.8B | |
| Low | 4.4B | 4.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.5% | 12.6% | |
| Avg | 5.8% | 7.2% | |
| Low | 3.0% | 0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.51 | 30.25 | |
| Avg | 25.39 | 25.61 | |
| Low | 24.38 | 22.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 228.3% | 19.1% | |
| Avg | 203.0% | 0.9% | |
| Low | 190.9% | -11.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.